(Circulation. 2005;112:1063-1072.)
© 2005 American Heart Association, Inc.
Contemporary Reviews in Cardiovascular Medicine |
From the Division of Cardiology (S.H.) and Neurological Institute (R.L.S.), Columbia University, New York, NY.
Correspondence to Shunichi Homma, MD, Division of Cardiology, Columbia University, College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032. E-mail sh23@columbia.edu
Key Words: anticoagulants aspirin embolism heart septal defects, atrial stroke
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
| Cryptogenic Stroke and PFO |
|---|
40% of patients with acute ischemic stroke, the cause remains undefined.1 PFO is a hemodynamically insignificant interatrial communication present in >25% of the adult population. During fetal life, because the lungs do not receive blood flow, blood returning to the right atrium is shunted through a PFO to the left atrium. Postnatally, PFO closes spontaneously in
75% of the population. However, in a portion of adults, by maintaining a direct communication between the right- and left-sided circulation, PFO can serve as a conduit for paradoxical embolization. In 1877, Cohnheim2 described the association of PFO with stroke in a young woman with cerebral arterial embolism. However, it has been difficult to diagnose PFO in vivo until the development of echocardiography and its ability to image the interatrial shunting with an injection of saline contrast. With the use of contrast echocardiography, a strong association of cryptogenic stroke with PFO has become evident in patients <55 years of age (Table 1).38
|
Because stroke occurs
This article has been cited by other articles:
![]() |
I. Monte, S. Grasso, S. Licciardi, and L. P. Badano Head-to-head comparison of real-time three-dimensional transthoracic echocardiography with transthoracic and transesophageal two-dimensional contrast echocardiography for the detection of patent foramen ovale Eur J Echocardiogr, November 28, 2009; (2009) jep195v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Alsheikh-Ali, D. E. Thaler, and D. M. Kent Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic? Stroke, July 1, 2009; 40(7): 2349 - 2355. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. O'Gara, S. R. Messe, E. M. Tuzcu, G. Catha, and J. C. Ring Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory J. Am. Coll. Cardiol., May 26, 2009; 53(21): 2014 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. O'Gara, S. R. Messe, E. M. Tuzcu, G. Catha, and J. C. Ring Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials: A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory. Circulation, May 26, 2009; 119(20): 2743 - 2747. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ford, G. S. Reeder, R. J. Lennon, R. D. Brown, G. W. Petty, A. K. Cabalka, F. Cetta, and D. J. Hagler Percutaneous Device Closure of Patent Foramen Ovale in Patients With Presumed Cryptogenic Stroke or Transient Ischemic Attack: The Mayo Clinic Experience J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 404 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yared, A. L. Baggish, J. Solis, R. Durst, J. J. Passeri, I. F. Palacios, and M. H. Picard Echocardiographic Assessment of Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure Complications Circ Cardiovasc Imaging, March 1, 2009; 2(2): 141 - 149. [Full Text] [PDF] |
||||
![]() |
A. Wahl, T. Tai, F. Praz, M. Schwerzmann, C. Seiler, K. Nedeltchev, S. Windecker, H. P. Mattle, and B. Meier Late Results After Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism Using the Amplatzer PFO Occluder Without Intraprocedural Echocardiography: Effect of Device Size J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 116 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sorajja and R. A. Nishimura Patent Foramen Ovale Closure Without Echocardiography: Are We Closing the Door Too Fast Too Soon? J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 124 - 126. [Full Text] [PDF] |
||||
![]() |
S. Windecker and B. Meier Patent Foramen Ovale and Cryptogenic Stroke: To Close or Not to Close? Closure: What Else! Circulation, November 4, 2008; 118(19): 1989 - 1997. [Full Text] [PDF] |
||||
![]() |
S. R. Messe and S. E. Kasner Patent Foramen Ovale in Cryptogenic Stroke: Not to Close Circulation, November 4, 2008; 118(19): 1999 - 2004. [Full Text] [PDF] |
||||
![]() |
F. Saremi, S. Channual, A. Raney, S. V. Gurudevan, J. Narula, S. Fowler, A. Abolhoda, and J. C. Milliken Imaging of Patent Foramen Ovale with 64-Section Multidetector CT Radiology, November 1, 2008; 249(2): 483 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Le Doare, S. Ameli-Renani, D. Banerjee, S. J. D. Brecker, and J. B. Eastwood Acute renal failure and multiple sites of ischaemia: what is the unifying diagnosis? NDT Plus, October 1, 2008; 1(5): 359 - 360. [Full Text] [PDF] |
||||
![]() |
D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 593S - 629S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bhindi and O. J. Ormerod Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect JAMA, May 21, 2008; 299(19): 2272 - 2272. [Full Text] [PDF] |
||||
![]() |
A. R. Opotowsky, M. J. Landzberg, and G. D. Webb Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect--Reply JAMA, May 21, 2008; 299(19): 2272 - 2273. [Full Text] [PDF] |
||||
![]() |
M. A. Meyer, C. Kunavarapu, J. A. Switzer, F. Nichols III, B. Silver, A. Russman, D. M. Kent, T. A. Trikalinos, D. E. Thaler, M. Handke, et al. Patent Foramen Ovale and Cryptogenic Stroke N. Engl. J. Med., April 3, 2008; 358(14): 1518 - 1521. [Full Text] [PDF] |
||||
![]() |
D Kenny, M Turner, and R Martin When to close a patent foramen ovale Arch. Dis. Child., March 1, 2008; 93(3): 255 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Mareedu, M. S. Shah, J. E. Mesa, and C. S. McCauley Percutaneous Closure of Patent Foramen Ovale: A Case Series and Literature Review Clin. Med. Res., December 1, 2007; 5(4): 218 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Meier Patent Foramen Ovale, Guilty But Only as a Gang Member and for a Lesser Crime J. Am. Coll. Cardiol., January 17, 2006; 47(2): 446 - 448. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |